Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Folic acid is highly effective for prevention of neural tube defects (NTDs) when administered in the first trimester of pregnancy and the benefits are linearly related to plasma folate levels. Folic acid also lowers plasma homocysteine that has been linked with risk of stroke. However, the effects of different folic acid fortification types on NTD prevalence and stroke are uncertain. This presentation will review current folic acid fortification policies and their relevance for NTD and stroke prevention.

Robert Clarke is a Professor of Epidemiology and Public Health Medicine, Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford. 

 

This talk is open to members of the University only.

Forthcoming events

Social evolution and social engineering in bacterial infection

Monday, 26 February 2024, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

What can genotyping studies tell us about on-farm transmission routes of Campylobacter?

Monday, 04 March 2024, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Oxford Festival of Global Health - Lovesick

Thursday, 07 March 2024, 4pm to 8pm @ The Curzon Cinema, The Westgate, Oxford

Title TBC

Monday, 15 April 2024, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms